Hält derzeit Positionen bei Savencia SA, Regulus Therapeutics Inc, Horizon Therapeutics PLC and Fresenius Medical Care AG & Co KGaA
Position | Company | Period |
---|---|---|
Independent Director | Savencia SA | 1. April 2016 - |
Independent Director | Regulus Therapeutics Inc | 1. Juni 2017 - |
Independent Director | Horizon Therapeutics PLC | 2. August 2017 - |
Independent Member of the Supervisory Board | Fresenius Medical Care AG & Co KGaA | 12. Mai 2016 - |
Executive Vice President, Diabetes and Cardiovascular, Member of the Executive Committee and the Global Leadership Team | Sanofi SA | None - |
Suchen
Datum der Benachrichtigung | Datum der Transaktion | K/V Art der Transaktion |
Anz. der Aktien Kurs Wert |
Anzahl der Aktien | Kurs | Gesamtwert | Details | |
---|---|---|---|---|---|---|---|---|
2019-05-08 | 2019-05-07 |
Regulus Therapeutics Inc
(RGLS)
|
K Kauf |
29.630
+360.5%
1,0832.000 USD |
29.630 +360.5% | 1,08 | 32.000 USD |